Edition:
United States

Zhejiang Jianfeng Group Co Ltd (600668.SS)

600668.SS on Shanghai Stock Exchange

12.58CNY
15 Aug 2018
Change (% chg)

¥-0.45 (-3.45%)
Prev Close
¥13.03
Open
¥13.07
Day's High
¥13.10
Day's Low
¥12.52
Volume
8,737,901
Avg. Vol
4,386,570
52-wk High
¥19.58
52-wk Low
¥10.81

Latest Key Developments (Source: Significant Developments)

Zhejiang Jianfeng Group unit receives GMP certificate
Tuesday, 8 May 2018 05:36am EDT 

May 8(Reuters) - Zhejiang Jianfeng Group Co Ltd <600668.SS>:Says co's Zhejiang-based pharmaceutical unit received GMP certificate from Zhejiang Food and Drug Administration, for a kind of bulk drug.Says the valid period is until May 2, 2023.  Full Article

Zhejiang Jianfeng Group says unit to invest in medical tech firm
Monday, 22 Jan 2018 03:18am EST 

Jan 22 (Reuters) - Zhejiang Jianfeng Group Co Ltd <600668.SS> ::Says its unit plans to use 111.3 million yuan to acquire shares and inject capital into a Shanghai-based medical tech firm, and will own a 55 percent stake after transaction .  Full Article

Zhejiang Jianfeng expects H1 net profit to rise 100-150 pct y/y
Monday, 17 Jul 2017 05:04am EDT 

July 17 (Reuters) - Zhejiang Jianfeng Group Co Ltd <600668.SS>:Says it expects H1 net profit to rise 100-150 percent y/y from 103.6 million yuan ($15.30 million) year ago.  Full Article

Zhejiang Jianfeng Group to pay cash div 2.5 yuan per 10 shares for FY 2016
Monday, 17 Apr 2017 11:31pm EDT 

April 18 (Reuters) - Zhejiang Jianfeng Group Co Ltd <600668.SS> ::* Says it plans to pay cash div 2.5 yuan per 10 shares for FY 2016.  Full Article

Zhejiang Jianfeng Group unit gets approval for clinic trials
Wednesday, 22 Mar 2017 05:30am EDT 

Zhejiang Jianfeng Group Co Ltd <600668.SS> :Says its pharma unit gets China Food and Drug Administration's approval for clinic trials of Deoxypodophyllotoxin and Deoxypodophyllotoxin for Injection.  Full Article

Zhejiang Jianfeng Group unit to acquire 50.7 pct stake in Beijing bio-tech firm
Thursday, 2 Mar 2017 04:17am EST 

Zhejiang Jianfeng Group Co., Ltd.<600668.SS>:Says its controlling pharmaceutical unit plans to acquire 50.7 percent stake in Beijing-based bio-technology firm step by step.  Full Article

Zhejiang Jianfeng Group unit signs letter of intent for cooperation
Wednesday, 12 Oct 2016 05:02am EDT 

Zhejiang Jianfeng Group Co Ltd <600668.SS>: Says its unit signed letter of intent for cooperation with a Guilin-based plant products company, for pharmaceutical business .Says its unit to invest in the Guilin-based plant products company's Beijing-based biotechnology subsidiary.  Full Article

No consensus analysis data available.